NAYA Biosciences Inc - Bathi mangsa ngarep NAYA

NAYA (NAYA Biosciences Inc) - tandha merek perusahaan

The expected financial results of NAYA Biosciences (NAYA) demonstrate a trend where represents the current metric. The business relies on a unique antibody creation system that establishes a long-term foundation for the development of targeted drugs. High potential pricing power is driven by the FLEX-NK platform, which activates immune cells. However, the lack of steady cash flow leaves the company dependent on external investments during the early trial period.

NAYA: Bathi mangsa ngarep nayabiosciences.com 04.07.2022 - 17.11.2026

NAYA Bio - rincian analitis lan metrik utama (NAYA)

Analisis fundamental perusahaan:NAYA, NAYA Bio
Barang utama NAYA Biosciences Inc

This indicator assesses the risk of a "value trap" by analyzing the dynamics of expected earnings to avoid betting on the perceived cheapness of an asset. For NAYA Biosciences (NAYA), the stability of these forecasts depends directly on the reliability of diversified biocomponent supply chains. By examining the projected net income metric, an investor can discern market expectations regarding the monetization of scientific developments. The trend in the projected net income metric reflects the business's resilience to operational shocks, allowing for an objective assessment of the company's fundamental value.

Perusahaan pesaing

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|ANL (adlainortye.com) - Bathi mangsa ngarep|VERU - Prakiraan bathi perusahaan|TPST (Tempest Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep xiliotx.com|Bathi sing dikarepake Enochian BioSciences (RENB)|Bathi sing dikarepake MURA (Mural Oncology PLC)|Bathi sing dikarepake Kairos Pharma Ltd KAPA|Proyeksi bathi mangsa ngarep OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Curis CRIS|APLM: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Tharimmune, Inc.|ADVB (Advanced Biomed) - Proyeksi bathi mangsa ngarep|Genprex - Bathi forward|Bathi sing dikarepake calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Bathi resik sing dikarepake|PPBT: Bathi mangsa ngarep|Penghasilan resik sing dikarepake AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Bathi sing dikarepake|Checkpoint Therapeutics, Inc (CKPT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Elevation Oncology, Inc.|ICAD: Penghasilan resik sing dikarepake|Bathi sing dikarepake ikenaoncology.com (IKNA)|Bathi sing dikarepake NTBL (Notable Labs, Ltd.)|Proyeksi bathi mangsa ngarep VIRX (viracta.com)|MOR - Bathi mangsa ngarep|AAPGV - Bathi sing dikarepake